Warning letter
Capco Custom Packaging Inc: warning letter of Feb 20, 2013
FDA warning letter 314018 · Los Angeles District Office
Key facts
| Reference number | 314018 |
|---|---|
| Company | Capco Custom Packaging Inc |
| Subject | CGMP/Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements/Adulterated |
| Issue date | Feb 20, 2013 |
| Posted date | Feb 20, 2013 |
| Issuing office | Los Angeles District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 111, 111.70, 111.73, 111.205, 111.210, 111.35(b)(3)(iii), 111.75(a)(2)(ii), 111.210(h)(3), 111.255(b), 111.260(b), 111.260(e), 111.260(f) and 14 more |
| Inspection city | Tempe |
| Inspection ZIP | 85281 |
| Inspection start date | May 4, 2012 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: